Antibiotic exposure does not influence MRP2 functional expression in Caco-2 cells
Authors:
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 13 (1) , 1-6
Abstract
Multidrug resistance-associated protein 2 (MRP2) is associated with active drug efflux and may influence oral bioavailability of common classes of drugs. MRP2 expression demonstrates plasticity. Caco-2 cells, a routine in vitro model for predicting oral bioavailability, are often cultured in media containing antibiotics. We have investigated whether exposure of Caco-2 cells to two common antibiotic regimes alters MRP2 functional expression. Caco-2 cells were grown in the presence or absence of either gentamicin or penicillin–streptomycin for up to 9 weeks. MRP2 functional activity was assessed by calcein efflux across the apical membrane. MRP2 protein expression was determined by immunoblots. Neither antibiotic regime resulted in consistent changes in calcein efflux across the apical membrane (reflecting MRP2 activity) or basolateral membrane (reflecting MRP3 and possibly MRP6 activity) of Caco-2 cells. MRP2 protein expression also showed no change in response to antibiotic exposure. Routine exposure of Caco-2 cells to penicillin–streptomycin or gentamicin does not affect apical MRP2 functional activity in intestinal enterocytic Caco-2 cells. Extrapolating these results to the situation in vivo suggests that the oral bioavailability of MRP substrates is not predicted to be influenced by recent courses of antibiotics.Keywords
This publication has 10 references indexed in Scilit:
- The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailabilityEuropean Journal of Pharmaceutical Sciences, 2004
- Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundiceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in ratsHepatology Research, 2002
- The Effect of Rifampin Treatment on Intestinal Expression of Human MRP TransportersThe American Journal of Pathology, 2000
- Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic AnionsMolecular Pharmacology, 2000
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampinJournal of Clinical Investigation, 1999
- Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.Journal of Clinical Investigation, 1998
- Kinetic Analysis of Calcein and Calcein−Acetoxymethylester Efflux Mediated by the Multidrug Resistance Protein and P-GlycoproteinBiochemistry, 1998
- Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorptionAdvanced Drug Delivery Reviews, 1997
- Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cellsFEBS Letters, 1996